Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nervenarzt ; 69(1): 70-5, 1998 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-9522336

RESUMO

Between January 1995 and June 1996, 24 inpatients at our hospital (mean age 55.6 years) were treated with electroconvulsive therapy (ECT). Clinical improvement was observed in 80% of the patients, including those without risk factors (NRG, n = 16), as well as those with concomitant cardiovascular diseases (RG, n = 8). During a mean period of observation of 224 days after the end of ECT 7 patients (35%) relapsed. The rate of relapse was higher in RG than in NRG patients (57.1 vs 23.1%). In all cases ECT was well tolerated; 285 applications of ECT did not result in mortality or persistent morbidity. However, RG patients may be at increased risk for the development of minor cardiovascular complications, which were noted in three RG patients (37.5%), but only in one patient (6.2%) in the NRG (Fisher's test, P = 0.09). Taken together, our results demonstrate that ECT is a safe treatment regimen for depression even in medically ill patients of old age.


Assuntos
Doenças Cardiovasculares/fisiopatologia , Eletroconvulsoterapia , Transtornos Psicóticos/terapia , Adulto , Idoso , Idoso de 80 Anos ou mais , Doenças Cardiovasculares/psicologia , Sistema Cardiovascular/fisiopatologia , Transtorno Depressivo/fisiopatologia , Transtorno Depressivo/psicologia , Transtorno Depressivo/terapia , Eletrocardiografia , Eletroconvulsoterapia/efeitos adversos , Eletroencefalografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Transtornos Psicóticos/fisiopatologia , Transtornos Psicóticos/psicologia , Fatores de Risco , Resultado do Tratamento
2.
Nervenarzt ; 67(3): 253-5, 1996 Mar.
Artigo em Alemão | MEDLINE | ID: mdl-8901285

RESUMO

A polydrug abuser had been prescribed clonidine for hypertonia but ingested it for its sedative properties and for euphoria over a period of 6 years. Intention and risk factors for clonidine abuse are discussed and the literature is reviewed. In suicidal patients and in those who present the potential for illicit drug use, we advise that clonidine be prescribed in the outpatient setting only when a safer alternative therapy proves unrealistic. When it is necessary to use clonidine, health care workers should be informed about the possibility of abuse and should observe the patients with utmost caution. To our knowledge this is the first documented case of clonidine abuse in a non-opioid-dependent patient.


Assuntos
Anti-Hipertensivos , Clonidina , Euforia/efeitos dos fármacos , Hipertensão/tratamento farmacológico , Transtornos Relacionados ao Uso de Substâncias/etiologia , Anti-Hipertensivos/efeitos adversos , Anti-Hipertensivos/uso terapêutico , Nível de Alerta/efeitos dos fármacos , Clonidina/efeitos adversos , Clonidina/uso terapêutico , Relação Dose-Resposta a Droga , Feminino , Humanos , Hipertensão/psicologia , Pessoa de Meia-Idade , Exame Neurológico/efeitos dos fármacos , Fatores de Risco , Síndrome de Abstinência a Substâncias/diagnóstico , Síndrome de Abstinência a Substâncias/etiologia , Transtornos Relacionados ao Uso de Substâncias/diagnóstico , Transtornos Relacionados ao Uso de Substâncias/reabilitação
3.
Dtsch Med Wochenschr ; 120(50): 1739-42, 1995 Dec 15.
Artigo em Alemão | MEDLINE | ID: mdl-8542810

RESUMO

HISTORY AND CLINICAL FINDINGS: A 22-year-old oligophrenic patient had on several occasions over several months been given various neuroleptics (haloperidol, benperidol, levomepromazine) for exacerbations of paranoid schizophrenia. For a few days before hospitalization he had become quiet and withdrawn, but on the day of admission 100 mg chlorprothixene was administered intramuscularly when he had become agitated. At admission he was somnolent, his general condition was disturbed. He had hyperhidrosis and hypersalivation, as well as tachycardia (112/min) with a normal body temperature of 37.8 degrees C. He also exhibited the cogwheel phenomenon of the limbs and neck, as well as tremor of the hands. The differential diagnosis included inflammatory disease of the brain, sinus thrombosis and, especially, malignant neuroleptic syndrome and febrile catatonia. INVESTIGATIONS: The activities of creatine kinase (3840 U/l), GOT (75 U/l) and GPT (88 U/l) were all increased. Serum myoglobin was 77 micrograms/l. CSF contained blood and there was pleocytosis of 50/3 cells. The ECG showed sinus tachycardia. EEG, chest radiogram, computed tomography, magnetic resonance imaging and cerebral angiography showed no abnormalities. Febrile catatonia could not be excluded. TREATMENT AND COURSE: 4 hours after admission the patient began to respond with normal orientation. Shortly afterwards he was able to walk a few steps, i.e. there was no catatonia. But rigor, tremor, hypersalivation and tachycardia persisted and 12 hours later he developed a fever (up to 39.2 degrees C). Blood pressure varied with peak pressures up to 190/110 mm Hg. After 2 days muscle tone had clearly increased so much that voluntary movement was hardly possible. After amantadine administration (200 mg daily) the rigor improved and for the first time body temperature became normal again. There were no signs pointing to psychotic symptoms. CONCLUSION: Neuroleptic malignant syndrome is difficult to distinguish from febrile catatonia and the diagnosis can often only be made through the clinical course.


Assuntos
Síndrome Maligna Neuroléptica/diagnóstico , Adulto , Amantadina/administração & dosagem , Antiparkinsonianos/administração & dosagem , Antipsicóticos/efeitos adversos , Bemperidol/efeitos adversos , Terapia Combinada , Diagnóstico Diferencial , Hidratação , Haloperidol/efeitos adversos , Humanos , Masculino , Metotrimeprazina/efeitos adversos , Síndrome Maligna Neuroléptica/etiologia , Síndrome Maligna Neuroléptica/terapia , Esquizofrenia Paranoide/complicações , Esquizofrenia Paranoide/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...